<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Endocrinol (Lausanne)</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Endocrinol (Lausanne)</journal-id>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Endocrinology</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26528239</article-id>
<article-id pub-id-type="pmc">4606117</article-id>
<article-id pub-id-type="doi">10.3389/fendo.2015.00160</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Oxytocin and Estrogen Receptor β in the Brain: An Overview</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Acevedo-Rodriguez</surname>
<given-names>Alexandra</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://frontiersin.org/people/u/173074" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mani</surname>
<given-names>Shaila K.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="http://frontiersin.org/people/u/28520" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Handa</surname>
<given-names>Robert J.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
<uri xlink:href="http://frontiersin.org/people/u/36215" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Neuroscience, Baylor College of Medicine</institution>, <addr-line>Houston, TX</addr-line>, <country>USA</country></aff>
<aff id="aff2"><sup>2</sup><institution>Memory and Brain Research Center, Baylor College of Medicine</institution>, <addr-line>Houston, TX</addr-line>, <country>USA</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department Molecular and Cellular Biology, Baylor College of Medicine</institution>, <addr-line>Houston, TX</addr-line>, <country>USA</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Biomedical Sciences, Colorado State University</institution>, <addr-line>Fort Collins, CO</addr-line>, <country>USA</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Deborah Suchecki, Universidade Federal de São Paulo, Brazil</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: René Hurlemann, University of Bonn, Germany; Aldo Lucion, Universidade Federal do Rio Grande do Sul, Brazil</p>
</fn>
<corresp content-type="corresp" id="cor1">*Correspondence: Robert J. Handa, <email>bhanda@colostate.edu</email></corresp>
<fn fn-type="other" id="fn001">
<p>Specialty section: This article was submitted to Neuroendocrine Science, a section of the journal Frontiers in Endocrinology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>10</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>6</volume>
<elocation-id>160</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>7</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>9</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2015 Acevedo-Rodriguez, Mani and Handa.</copyright-statement>
<copyright-year>2015</copyright-year>
<copyright-holder>Acevedo-Rodriguez, Mani and Handa</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Oxytocin (OT) is a neuropeptide synthesized primarily by neurons of the paraventricular and supraoptic nuclei of the hypothalamus. These neurons have axons that project into the posterior pituitary and release OT into the bloodstream to promote labor and lactation; however, OT neurons also project to other brain areas where it plays a role in numerous brain functions. OT binds to the widely expressed OT receptor (OTR), and, in doing so, it regulates homeostatic processes, social recognition, and fear conditioning. In addition to these functions, OT decreases neuroendocrine stress signaling and anxiety-related and depression-like behaviors. Steroid hormones differentially modulate stress responses and alter OTR expression. In particular, estrogen receptor β activation has been found to both reduce anxiety-related behaviors and increase OT peptide transcription, suggesting a role for OT in this estrogen receptor β-mediated anxiolytic effect. Further research is needed to identify modulators of OT signaling and the pathways utilized and to elucidate molecular mechanisms controlling OT expression to allow better therapeutic manipulations of this system in patient populations.</p>
</abstract>
<kwd-group>
<kwd>estradiol</kwd>
<kwd>oxytocin</kwd>
<kwd>hypothalamus</kwd>
<kwd>pituitary</kwd>
<kwd>adrenal</kwd>
<kwd>behavior</kwd>
<kwd>anxiety</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn01">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content></funding-source>
<award-id rid="cn01">R01 NS039951</award-id>
<award-id rid="cn01">CH062512</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="75"></ref-count>
<page-count count="7"></page-count>
<word-count count="5880"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p>The nonapeptide hormone, oxytocin (OT), has gained widespread attention as a potential therapeutic agent in a myriad of disorders, including autism spectrum disorder, schizophrenia, and addiction (<xref ref-type="bibr" rid="B1">1</xref>). OT is produced primarily in the neurons of the hypothalamic paraventricular nucleus (PVN) and supraoptic nucleus [SON (<xref ref-type="bibr" rid="B2">2</xref>)], is released into systemic circulation, and plays an important role in lactation, parturition, maternal behavior, and pair-bond formation (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). Additionally, OT is released from the PVN axon terminals that project throughout the brain into regions, such as the hippocampus, striatum, and amygdala (<xref ref-type="bibr" rid="B5">5</xref>), and has been implicated in the regulation of memory, stress, and social behaviors (<xref ref-type="bibr" rid="B1">1</xref>). In addition to traditional release across a synapse, OT is also released from neuron somas and dendrites and can reach nearby brain regions via volume transmission by diffusing across neural tissue (<xref ref-type="bibr" rid="B6">6</xref>). In this review, we focus on the function of OT in the brain and its modulation by estrogens.</p>
</sec>
<sec id="S2">
<title>Oxytocin Receptors: Brain Distribution and Function</title>
<p>Oxytocin signals through OT receptors (OTRs), which are G protein-coupled receptors that, upon binding to OT, activate the Gq protein subunit and ultimately excite the cell. Autoradiographic studies have identified OTR expression in several regions of the rat brain, including the olfactory system, basal ganglia, hippocampus, central amygdala, and hypothalamus (<xref ref-type="bibr" rid="B7">7</xref>). The generation of a knock-in mouse strain where Venus, a variant of yellow fluorescent protein, is under the regulation of the <italic>Otr</italic> promoter sequence, facilitated the identification of OTR expressing cells in additional brain regions, e.g., the median raphe nucleus and the lateral hypothalamus. This mouse model has been valuable in the identification of the phenotype of the cells expressing OTRs. For instance, OTRs have been found in serotonergic neurons (<xref ref-type="bibr" rid="B8">8</xref>), implicating serotonergic involvement in OTs anxiolytic effects in depression and anxiety.</p>
<p>Central OT is important in homeostatic processes, such as thermoregulation (<xref ref-type="bibr" rid="B9">9</xref>), food intake (<xref ref-type="bibr" rid="B10">10</xref>), and mating (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>). OT also plays an important role in maternal behavior. Female rats that received and exhibited high maternal care showed higher levels of OTRs in various limbic regions of the brain, including the bed nucleus of the stria terminalis (BNST), central nucleus of the amygdala (CeA), lateral septum (LS), PVN, and medial preoptic area (MPOA). Additionally, central administration of an OTR antagonist (OTA) completely eliminated the elevated licking and grooming behaviors seen in the high maternal behavior animals, suggesting that OTRs mediate maternal behaviors (<xref ref-type="bibr" rid="B13">13</xref>).</p>
<p>Additional insights into the function of OT and the OTR are gained from the examination of genetically engineered mouse models. Female OT knockout (OTKO) mice show normal parturition and maternal behavior but are unable to nurse their pups demonstrating that in the mouse OT is not necessary for maternal behavior or labor but is essential for milk ejection (<xref ref-type="bibr" rid="B14">14</xref>). Compared to the normal maternal behavior observed in OTKOs, OTR knockout (OTRKO) mice show deficits in maternal behaviors demonstrated by their longer latency for pup retrieval (<xref ref-type="bibr" rid="B15">15</xref>). OT signaling is also implicated in social behavior, and the OTKOs and OTRKOs both showed deficits in social memory. Wild-type animals investigate a novel conspecific for a longer period of time than a familiar animal, whereas OTKOs and OTRKOs show similar investigation times for both novel and familiar animals (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). Although OTR levels remain unaltered in OTKOs (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>), OTKOs demonstrated increased OTR sensitivity as measured by increased grooming following central OT administration (<xref ref-type="bibr" rid="B17">17</xref>).</p>
<p>Unlike OTKOs, OTRKO males display increased aggression in the resident-intruder task (<xref ref-type="bibr" rid="B15">15</xref>). It is possible that this elevated aggressive behavior in the OTRKOs is mediated by a lack of OT signaling in the CeA, since administration of OT into the CeA of male rats decreased aggressive behavior (<xref ref-type="bibr" rid="B18">18</xref>). Interestingly, OTKO offspring generated from a homozygous breeding scheme demonstrated an increased aggression phenotype as compared to those bred from heterozygous parents, suggesting that OT from the heterozygous dam can prevent the aggressive phenotype in the OTKO pups (<xref ref-type="bibr" rid="B15">15</xref>). Although these changes in behavior may relate to the absence of OT or the OTR, these phenotypic changes could be due to compensatory mechanisms that occur during development to overcome the absence of OT signaling.</p>
<p>Furthermore, selective knockout of OTRs in the LS showed that OT plays a bi-directional role in fear regulation dependent on social context. Animals exposed to a non-fearful conspecific [positive social encounter; (<xref ref-type="bibr" rid="B19">19</xref>)] or to social defeat [negative social encounter; (<xref ref-type="bibr" rid="B20">20</xref>)] during contextual fear conditioning showed reduced or increased fear, respectively, compared to controls. Intra-LS administration of OTA or of a virally linked Cre-recombinase to knockdown OTR expression prevented the altered fear response mediated by the social stimulus (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>). These data demonstrate that the OT/OTR system enhances memory of social interactions, reducing fear after positive and enhancing fear after negative social interactions.</p>
<p>Various factors influence OT signaling. OTRs are largely expressed centrally but their regional localization varies across species. For instance, mice and rats both express OTRs in the ventromedial nucleus of the hypothalamus [VMH (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>)], but OTRs are not expressed in this region in rabbits (<xref ref-type="bibr" rid="B7">7</xref>). These species-specific differences in localization may account for different responses to OT, for example, mice and rats respond differently to OT administration (<xref ref-type="bibr" rid="B21">21</xref>). Additionally, mice and humans show different OTR localization. For example, OTR-Venus immunoreactivity was seen in the mouse hippocampus (<xref ref-type="bibr" rid="B8">8</xref>) but, in humans, OTRs were not localized to this area (<xref ref-type="bibr" rid="B22">22</xref>). OTR signaling also changes during development in rats with transient developmental patterns displayed postnatally, an adult-like expression pattern seen around postnatal day 21, and increased OTR quantities into adulthood (<xref ref-type="bibr" rid="B23">23</xref>). Additionally, OT signaling differs between males and females. Female rats were found to have fewer OTRs in the BNST, VMH, and medial amygdala compared to males (<xref ref-type="bibr" rid="B24">24</xref>), and in humans, men and women were found to respond differently to intranasal OT administration (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>). These differences between males and females may relate to hormone differences, which alter OT signaling and are discussed in more detail in a later section.</p>
</sec>
<sec id="S3">
<title>Oxytocin Regulation of Hypothalamic–Pituitary–Adrenal Axis</title>
<p>Oxytocin release from neurons of the PVN and the presence of OTRs within the PVN suggests the possibility that OT can directly modulate the stress reactive hypothalamic–pituitary–adrenal (HPA) axis. The HPA axis responds to stressors and activates neurons residing in the PVN causing increased synthesis and secretion of corticotropin-releasing factor (CRF). The release of CRF into the hypophyseal portal system enhances synthesis and release of adrenocorticotropic hormone (ACTH) from the anterior pituitary. In turn, ACTH acts on the adrenal cortex to stimulate release of glucocorticoids [cortisol in humans and corticosterone (CORT) in rats and mice]. Increased levels of circulating glucocorticoids can further inhibit HPA axis activity via glucocorticoid and mineralocorticoid receptors in the brain as well as acting upon specific brain sites to modulate behaviors (<xref ref-type="bibr" rid="B27">27</xref>).</p>
<p>Oxytocin can putatively impact several sites within the HPA axis. PVN neurons that project to the median eminence release OT into the hypophyseal portal vasculature to stimulate adrenal glucocorticoid release by potentiating the actions of CRF at the anterior pituitary level in a similar fashion to the closely related neuropeptide vasopressin (<xref ref-type="bibr" rid="B28">28</xref>). By contrast, OT neurons in the PVN that project into the forebrain and release OT in response to stressors (<xref ref-type="bibr" rid="B29">29</xref>) exert anxiolytic actions (<xref ref-type="bibr" rid="B5">5</xref>). Intracerebroventricular (ICV) administration of OT decreases not only circulating CORT levels but also ACTH levels following exposure to stressors in rats (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>) and mice (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>), and central infusion of OT into the PVN inhibits HPA axis reactivity, via modulation of CRF neuronal activity (<xref ref-type="bibr" rid="B34">34</xref>). Using the restraint stress paradigm in association with OT administration (ICV), Windle et al. (<xref ref-type="bibr" rid="B31">31</xref>) demonstrated the presence of an OT-sensitive forebrain stress circuit involving the dorsal hippocampus, ventrolateral septum, and PVN (<xref ref-type="bibr" rid="B31">31</xref>).</p>
<p>Endogenous OT levels are also sufficient to alter HPA axis reactivity. ICV injection of OTA showed elevated ACTH and CORT levels prior to behavioral testing suggesting that endogenous OT levels can suppress HPA axis reactivity (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>). Additionally, administration of OTA via retrodialysis into the PVN resulted in increased ACTH and CORT release indicating that endogenous OT can inhibit PVN neurons (<xref ref-type="bibr" rid="B35">35</xref>). Female OTKO mice show elevated CORT levels following acute and repeated shaker stress compared to wild-type littermates (<xref ref-type="bibr" rid="B33">33</xref>), demonstrating a definitive role for OT in regulating HPA axis reactivity to stress.</p>
<p>Interestingly, OT also promotes social buffering in response to stress, similar to the effect seen with fear (<xref ref-type="bibr" rid="B19">19</xref>). Female prairie voles subjected to restraint stress demonstrated an increase in anxiety-like behaviors and CORT levels when recovering alone but not when recovering with a male partner, which also corresponded to an increase in OT release in the PVN of these females. Intra-PVN OT injections reduced CORT and anxiety-related behaviors when animals recovered alone, whereas intra-PVA OTA administration prevented social buffering. These observations suggest that PVN OT signaling is necessary and sufficient for social buffering effects in response to stress in prairie voles (<xref ref-type="bibr" rid="B36">36</xref>).</p>
</sec>
<sec id="S4">
<title>Oxytocin Regulation of Anxiety and Depressive Behaviors</title>
<p>Oxytocin is strongly implicated in social bond formation and social behavior [for review see Ref. (<xref ref-type="bibr" rid="B37">37</xref>)], but may also play a role in psychiatric disorders, such as anxiety and depression. The effect of OT in these disorders may be related to abnormal social behavior, but OT may also independently impact these disorders via regulation of the HPA axis. Dysregulation of the HPA axis and increased response to stressors are commonly seen in anxiety and mood disorders (<xref ref-type="bibr" rid="B38">38</xref>). In a clinical study with pediatric and adult participants, cerebrospinal fluid and plasma OT levels were found to be higher in participants that had lower anxiety (<xref ref-type="bibr" rid="B39">39</xref>). However, severe anxiety symptoms may be related to over-activation of the OT system as women with elevated OT levels were more likely to report being anxious on a daily basis (<xref ref-type="bibr" rid="B40">40</xref>). Reduced nocturnal levels of OT have been reported in depressed individuals; however, numerous studies have also reported no differences compared to healthy controls (<xref ref-type="bibr" rid="B41">41</xref>). This variability across studies for anxiety and depression may relate to OT levels corresponding more to personality traits rather than symptoms of depression or anxiety (<xref ref-type="bibr" rid="B42">42</xref>). Despite these inconsistencies in data concerning psychiatric disorder OT levels, a recent meta-analysis suggests that OT may be beneficial in the treatment of anxiety and depression (<xref ref-type="bibr" rid="B43">43</xref>).</p>
<p>Oxytocin signaling during early development may contribute to later anxiety. Prairie vole pups exposed to a single injection of OT on postnatal day 1 demonstrated an increase in serotonergic axon density in the anterior hypothalamus, cortical amygdala, and VMH but not in the PVN or medial amygdala. Such effects on serotonergic neurons could be a mechanism by which OT affects emotional behaviors, since serotonin is strongly linked to mood, and serotonin dysregulation is seen in depression and anxiety disorders (<xref ref-type="bibr" rid="B44">44</xref>).</p>
<p>In adult animals, OT administration reduces anxiety-related behaviors in the elevated plus maze (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>) and open field assay (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B11">11</xref>). OT administration centrally (<xref ref-type="bibr" rid="B30">30</xref>), to the medial prefrontal cortex (<xref ref-type="bibr" rid="B46">46</xref>), to the CeA (<xref ref-type="bibr" rid="B11">11</xref>), and to the PVN (<xref ref-type="bibr" rid="B45">45</xref>) was sufficient to reduce anxiety-related behaviors. Chronic central OT administration reduced anxiety in rats bred for high levels of anxiety-related behaviors (<xref ref-type="bibr" rid="B47">47</xref>). Further support for the role of OT in reducing anxiety comes from studies of OTKO mice with OTKO females showing increased anxiety-related behaviors compared to their wild-type counterparts (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). The effect of OT was sex dependent as male OTKOs showed reduced anxiety-related behaviors (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B48">48</xref>).</p>
<p>Oxytocin also reduces measures of depression in the forced swim test (FST) and tail suspension test. In FST, rats treated with an OT analog spent less time immobile and more time swimming and climbing the walls of the chamber than saline-treated animals indicating an antidepressant effect (<xref ref-type="bibr" rid="B49">49</xref>). Similarly, ICV OT or OTA administration showed a dose-dependent decrease or increase in immobility in both assays, respectively (<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B51">51</xref>). Interestingly, the antidepressant effect of OT was not blocked by a selective OTA, suggesting that OTs antidepressant effects are not OTR mediated (<xref ref-type="bibr" rid="B50">50</xref>).</p>
</sec>
<sec id="S5">
<title>Regulation of Oxytocin Function by Steroid Hormones</title>
<p>Steroid hormones are a broad family of hormones that include the estrogens, androgens, progestins, mineralocorticoids, and glucocorticoids. These hormones can readily cross the cell membrane where they bind and activate their respective intracellular receptors. Steroid receptor proteins have DNA and ligand-binding domains, and unliganded steroid receptors are maintained in an inactive state by a complex of chaperone proteins (<xref ref-type="bibr" rid="B52">52</xref>). Upon ligand binding, the receptors dimerize and translocate into the nucleus and bind DNA promoters and recruit cofactors and transcription machinery to promote gene transcription (<xref ref-type="bibr" rid="B53">53</xref>). Steroid hormones have been found to alter OT signaling. Estrogens can act in a synergistic manner with OT, not only by enhancing its anxiolytic effects (<xref ref-type="bibr" rid="B54">54</xref>) but also by increasing OTR levels in the mouse brain (<xref ref-type="bibr" rid="B55">55</xref>). In humans, a single dose of estradiol was sufficient to increase plasma OT levels in women (<xref ref-type="bibr" rid="B56">56</xref>). Similarly, testosterone alters OTR expression differently depending on brain region (<xref ref-type="bibr" rid="B21">21</xref>). Progesterone is important in pregnancy maintenance and <italic>in vitro</italic> studies found that progesterone could inhibit OT binding to the OTR (<xref ref-type="bibr" rid="B57">57</xref>). Also, treatment with a synthetic glucocorticoid significantly altered OTR expression in various brain regions, such as the amygdala, BNST, and VMH (<xref ref-type="bibr" rid="B58">58</xref>).</p>
<p>Understanding OT regulation by sex steroids is important since anxiety and depressive disorders show a larger gender disparity (<xref ref-type="bibr" rid="B38">38</xref>), which may be related to circulating steroid hormone levels. Testosterone has been shown to decrease HPA axis activity (<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>), whereas estrogens can both increase (<xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B61">61</xref>) or decrease (<xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B63">63</xref>) HPA axis activity, and these alterations may in part be through modulations of OT activity. The differences in the observed effects of estrogens on behavior and neuroendocrine responses to stress may relate to its differential activity on ERα and ERβ. Activation of ERα can increase HPA axis activity, whereas activation of ERβ has the opposite effect (<xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B64">64</xref>). Although ERα-mediated activity modulates OTR transcription, ERβ-mediated activity has been found to alter <italic>Ot</italic> mRNA levels (<xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B66">66</xref>). Moreover, androgen modulation of OT appears to be mediated in part by the testosterone metabolite 3β-diol, which activates ERβ to allow binding to the <italic>Ot</italic> promoter to increases <italic>Ot</italic> mRNA (<xref ref-type="bibr" rid="B67">67</xref>).</p>
</sec>
<sec id="S6">
<title>Estrogen Receptor β and Oxytocin Interactions in Regulation HPA Axis and Anxiety-Related Behaviors</title>
<p>Activation of ERβ reduces HPA axis activity, as seen by reductions in ACTH levels and CORT levels, in mice (<xref ref-type="bibr" rid="B68">68</xref>) and rats (<xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B70">70</xref>) following a stressor. ERβ receptors are expressed widely throughout the brain and often overlap with ERα expression (<xref ref-type="bibr" rid="B71">71</xref>), except in the PVN of rats where only ERβ is expressed (<xref ref-type="bibr" rid="B72">72</xref>). Interestingly, approximately 85% of OT neurons in the PVN co-express ERβ (<xref ref-type="bibr" rid="B72">72</xref>), and activation of ERβ within the PVN, with the ERβ-specific agonist diarylpropionitrile (DPN) or testosterone metabolite 3β-diol, reduces HPA axis activity following restraint stress in rats (<xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B73">73</xref>). Treatment with estradiol increases <italic>Ot</italic> mRNA expression in the brains of wild-type mice, but not in ERβ knockout (ERβKO) mice in both males (<xref ref-type="bibr" rid="B65">65</xref>) and females (<xref ref-type="bibr" rid="B66">66</xref>). This ERβ-mediated increase in <italic>Ot</italic> mRNA was specific to the PVN and not seen in the MPOA, SON (<xref ref-type="bibr" rid="B65">65</xref>), medial amygdala, or VMH (<xref ref-type="bibr" rid="B66">66</xref>).</p>
<p>The substantial overlap in the distribution of ERβ and OT in the PVN suggests a potential interaction between the two in the regulation of HPA axis activity. As previously discussed, activation of ERβ reduced HPA axis reactivity and anxiety-like behaviors in rats and mice (<xref ref-type="bibr" rid="B64">64</xref>, <xref ref-type="bibr" rid="B68">68</xref>, <xref ref-type="bibr" rid="B70">70</xref>). ICV treatment with OTA, however, blocked the ERβ agonist-mediated reduction of anxiety-related behaviors and CORT secretion (<xref ref-type="bibr" rid="B70">70</xref>), suggesting interaction between ERβ signaling pathways and OTergic pathways in the control of anxiety-related behaviors and HPA axis reactivity in stress. Currently, the mechanisms involved in the crosstalk between these two pathways are not completely understood.</p>
<p>Recent studies have begun to investigate the complex interaction between ERβ and the <italic>Ot</italic> promoter. Using a mouse hypothalamic cell line expressing ERβ and OT, Sharma et al. (<xref ref-type="bibr" rid="B74">74</xref>) demonstrated <italic>Ot</italic> promoter occupancy by ERβ. The <italic>Ot</italic> promoter has a composite hormone response element, which allows for steroid receptor binding and <italic>Ot</italic> gene transcription regulation by ERs and other members of the nuclear receptor family but not the other steroid hormone receptors (<xref ref-type="bibr" rid="B75">75</xref>). Treatment of a neuronal cell line with the ERβ agonists, 3β-diol, DPN, or estradiol, elicited increases in <italic>Ot</italic> mRNA levels and <italic>Ot</italic> promoter occupancy (<xref ref-type="bibr" rid="B67">67</xref>, <xref ref-type="bibr" rid="B74">74</xref>). In tandem with ERβ occupancy of the <italic>Ot</italic> promoter, cAMP response element-binding protein (CBP) and steroid receptor coactivator (SRC)-1 were found to occupy the <italic>Ot</italic> promoter, leading to increased acetylation of histone H4 in the presence of 3β-diol. Taken together, the data suggest that in the presence of 3β-diol, ERβ binds the <italic>Ot</italic> promoter and recruits ligand-dependent coactivator SRC-1, which binds CBP, and forms a functional complex that acetylates histone H4 to drive <italic>Ot</italic> gene expression (<xref ref-type="bibr" rid="B74">74</xref>). The role of ERβ related to OT signaling at the molecular level and its larger role in OT signaling throughout the brain are summarized in Figure <xref ref-type="fig" rid="F1">1</xref>. Further studies are needed to determine the extent of the binding of ERβ to the <italic>Ot</italic> promoter, the co-activators recruited, and how this interaction modulates HPA axis function <italic>in vivo</italic>.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p><bold>Overview of estrogen receptor β (ERβ) action in oxytocin neurons of the paraventricular nucleus (PVN) and oxytocin signaling</bold>. <bold>(A)</bold> ERβ signaling in PVN oxytocinergic neurons. (1) Estrogen enters the cell and binds to inactive ERβ. In its inactive form, ERβ is bound to a complex of chaperone proteins. (2) Upon binding its ligand, ERβ dimerizes. (3) The dimerized receptor binds to the composite hormone response element (cHRE) of the oxytocin promoter. Co-activators, such are SRC-1 and CBP, are recruited along with the transcription machinery to promote transcription. (4) Ultimately, the oxytocin peptide is produced. <bold>(B)</bold> Oxytocin signaling in the brain. Oxytocin is produced in neurons of the PVN and supraoptic nucleus (SON). Oxytocin neurons from both regions project to the posterior pituitary (P Pit). In addition to this release, the PVN also sends oxytocin projections throughout the brain (<xref ref-type="bibr" rid="B5">5</xref>). ERβ is expressed in approximately 85% of neurons in the rodent PVN but not in the SON (<xref ref-type="bibr" rid="B72">72</xref>). This suggests that ERβ could play a role in increasing oxytocin production in regions important in responding to stress and can subsequently influence brain areas that express oxytocin receptors [shown in blue; (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B13">13</xref>)]. BNST, bed nucleus of the stria terminalis; DR, dorsal raphe nucleus; LS, lateral septum; MnR, median raphe nucleus; PFC, prefrontal cortex.</p>
</caption>
<graphic xlink:href="fendo-06-00160-g001"></graphic>
</fig>
</sec>
<sec id="S7" sec-type="conclusions">
<title>Conclusion</title>
<p>Oxytocin has a wide range of roles in the brain and allows interesting and important directions for research. Current data suggest that the OT neurons of the PVN provide the principal OTergic innervation of the forebrain. The function of OT, through OTRs, is regionally specific; however, the localization of OTRs varies across species, age, and sex, so separating the effect of these variables is necessary to determine how animal studies translate to humans. Modulators of the OT system, particularly the steroid hormones, also provide additional regulatory targets since OT modulates HPA axis reactivity and participates in many diverse functions. In particular, ERβ is expressed by many neurons of the PVN, and ERβ activation increases OT synthesis and reduces anxiety and neuroendocrine responses in animals. Hence, such targets may be fruitful directions for future focus.</p>
</sec>
<sec id="S8">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<sec id="S9">
<title>Funding</title>
<p>The research programs of the authors have been funded by NS039951 (RJH) and CH062512 (SKM).</p>
</sec>
<sec id="S10">
<title>Abbreviations</title>
<p>ACTH, adrenocorticotropic hormone; BNST, bed nucleus of the stria terminalis; CBP, cAMP response element-binding protein; CeA, central nucleus of the amygdala; CORT, corticosterone; CRF, corticotropin-releasing factor; DPN, diarylpropionitrile; ERα, estrogen receptor α; ERβ, estrogen receptor β; ERβKO, ERβ knockout; FST, forced swim test; GABA, γ-aminobutyric acid; HPA, hypothalamic–pituitary–adrenal; ICV, intracerebroventricular; LS, lateral septum; MPOA, medial preoptic area; OT, oxytocin; OTA, oxytocin receptor antagonist; OTKO, oxytocin knockout; OTR, oxytocin receptor; OTRKO, oxytocin receptor knockout; PVN, paraventricular nucleus of the hypothalamus; SRC, steroid receptor coactivator; VMH, ventromedial nucleus of the hypothalamus.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olff</surname><given-names>M</given-names></name><name><surname>Frijling</surname><given-names>JL</given-names></name><name><surname>Kubzansky</surname><given-names>LD</given-names></name><name><surname>Bradley</surname><given-names>B</given-names></name><name><surname>Ellenbogen</surname><given-names>MA</given-names></name><name><surname>Cardoso</surname><given-names>C</given-names></name><etal></etal></person-group>
<article-title>The role of oxytocin in social bonding, stress regulation and mental health: an update on the moderating effects of context and interindividual differences</article-title>. <source/>Psychoneuroendocrinology (<year>2013</year>) <volume>38</volume>:<fpage>1883</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1016/j.psyneuen.2013.06.019</pub-id><pub-id pub-id-type="pmid">23856187</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onaka</surname><given-names>T</given-names></name></person-group>. <article-title>Neural pathways controlling central and peripheral oxytocin release during stress</article-title>. <source/>J Neuroendocrinol (<year>2004</year>) <volume>16</volume>:<fpage>308</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1111/j.0953-8194.2004.01186.x</pub-id><pub-id pub-id-type="pmid">15089967</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>CS</given-names></name></person-group>. <article-title>Developmental consequences of oxytocin</article-title>. <source/>Physiol Behav (<year>2003</year>) <volume>79</volume>:<fpage>383</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="doi">10.1016/S0031-9384(03)00151-3</pub-id><pub-id pub-id-type="pmid">12954433</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiss</surname><given-names>A</given-names></name><name><surname>Mikkelsen</surname><given-names>JD</given-names></name></person-group>. <article-title>Oxytocin – anatomy and functional assignments: a minireview</article-title>. <source/>Endocr Regul (<year>2005</year>) <volume>39</volume>:<fpage>97</fpage>–<lpage>105</lpage>.<pub-id pub-id-type="pmid">16468232</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knobloch</surname><given-names>HS</given-names></name><name><surname>Charlet</surname><given-names>A</given-names></name><name><surname>Hoffmann</surname><given-names>LC</given-names></name><name><surname>Eliava</surname><given-names>M</given-names></name><name><surname>Khrulev</surname><given-names>S</given-names></name><name><surname>Cetin</surname><given-names>AH</given-names></name><etal></etal></person-group>
<article-title>Evoked axonal oxytocin release in the central amygdala attenuates fear response</article-title>. <source/>Neuron (<year>2012</year>) <volume>73</volume>:<fpage>553</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuron.2011.11.030</pub-id><pub-id pub-id-type="pmid">22325206</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>CS</given-names></name></person-group>. <article-title>Oxytocin pathways and the evolution of human behavior</article-title>. <source/>Annu Rev Psychol (<year>2014</year>) <volume>65</volume>:<fpage>17</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-psych-010213-115110</pub-id><pub-id pub-id-type="pmid">24050183</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gimpl</surname><given-names>G</given-names></name><name><surname>Fahrenholz</surname><given-names>F</given-names></name></person-group>. <article-title>The oxytocin receptor system: structure, function, and regulation</article-title>. <source/>Physiol Rev (<year>2001</year>) <volume>81</volume>:<fpage>629</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">11274341</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Takayanagi</surname><given-names>Y</given-names></name><name><surname>Inoue</surname><given-names>K</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Young</surname><given-names>LJ</given-names></name><name><surname>Onaka</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice</article-title>. <source/>J Neurosci (<year>2009</year>) <volume>29</volume>:<fpage>2259</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5593-08.2009</pub-id><pub-id pub-id-type="pmid">19228979</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasahara</surname><given-names>Y</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Takayanagi</surname><given-names>Y</given-names></name><name><surname>Mizukami</surname><given-names>H</given-names></name><name><surname>Ozawa</surname><given-names>K</given-names></name><name><surname>Hidema</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Oxytocin receptor in the hypothalamus is sufficient to rescue normal thermoregulatory function in male oxytocin receptor knockout mice</article-title>. <source/>Endocrinology (<year>2013</year>) <volume>154</volume>:<fpage>4305</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1210/en.2012-2206</pub-id><pub-id pub-id-type="pmid">24002032</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maejima</surname><given-names>Y</given-names></name><name><surname>Sakuma</surname><given-names>K</given-names></name><name><surname>Santoso</surname><given-names>P</given-names></name><name><surname>Gantulga</surname><given-names>D</given-names></name><name><surname>Katsurada</surname><given-names>K</given-names></name><name><surname>Ueta</surname><given-names>Y</given-names></name><etal></etal></person-group>
<article-title>Oxytocinergic circuit from paraventricular and supraoptic nuclei to arcuate POMC neurons in hypothalamus</article-title>. <source/>FEBS Lett (<year>2014</year>) <volume>588</volume>:<fpage>4404</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1016/j.febslet.2014.10.010</pub-id><pub-id pub-id-type="pmid">25448678</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bale</surname><given-names>TL</given-names></name><name><surname>Davis</surname><given-names>AM</given-names></name><name><surname>Auger</surname><given-names>AP</given-names></name><name><surname>Dorsa</surname><given-names>DM</given-names></name><name><surname>McCarthy</surname><given-names>MM</given-names></name></person-group>. <article-title>CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior</article-title>. <source/>J Neurosci (<year>2001</year>) <volume>21</volume>:<fpage>2546</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="pmid">11264328</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gil</surname><given-names>M</given-names></name><name><surname>Bhatt</surname><given-names>R</given-names></name><name><surname>Picotte</surname><given-names>KB</given-names></name><name><surname>Hull</surname><given-names>EM</given-names></name></person-group>. <article-title>Oxytocin in the medial preoptic area facilitates male sexual behavior in the rat</article-title>. <source/>Horm Behav (<year>2011</year>) <volume>59</volume>:<fpage>435</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1016/j.yhbeh.2010.12.012</pub-id><pub-id pub-id-type="pmid">21195714</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Champagne</surname><given-names>F</given-names></name><name><surname>Diorio</surname><given-names>J</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Meaney</surname><given-names>MJ</given-names></name></person-group>. <article-title>Naturally occurring variations in maternal behavior in the rat are associated with differences in estrogen-inducible central oxytocin receptors</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2001</year>) <volume>98</volume>:<fpage>12736</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.221224598</pub-id><pub-id pub-id-type="pmid">11606726</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimori</surname><given-names>K</given-names></name><name><surname>Young</surname><given-names>LJ</given-names></name><name><surname>Guo</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Insel</surname><given-names>TR</given-names></name><name><surname>Matzuk</surname><given-names>MM</given-names></name></person-group>. <article-title>Oxytocin is required for nursing but is not essential for parturition or reproductive behavior</article-title>. <source/>Proc Natl Acad Sci U S A (<year>1996</year>) <volume>93</volume>:<fpage>11699</fpage>–<lpage>704</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.93.21.11699</pub-id><pub-id pub-id-type="pmid">8876199</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takayanagi</surname><given-names>Y</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Bielsky</surname><given-names>IF</given-names></name><name><surname>Ross</surname><given-names>HE</given-names></name><name><surname>Kawamata</surname><given-names>M</given-names></name><name><surname>Onaka</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2005</year>) <volume>102</volume>:<fpage>16096</fpage>–<lpage>101</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0505312102</pub-id><pub-id pub-id-type="pmid">16249339</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>JN</given-names></name><name><surname>Young</surname><given-names>LJ</given-names></name><name><surname>Hearn</surname><given-names>EF</given-names></name><name><surname>Matzuk</surname><given-names>MM</given-names></name><name><surname>Insel</surname><given-names>TR</given-names></name><name><surname>Winslow</surname><given-names>JT</given-names></name></person-group>. <article-title>Social amnesia in mice lacking the oxytocin gene</article-title>. <source/>Nat Genet (<year>2000</year>) <volume>25</volume>:<fpage>284</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/77040</pub-id><pub-id pub-id-type="pmid">10888874</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amico</surname><given-names>JA</given-names></name><name><surname>Vollmer</surname><given-names>RR</given-names></name><name><surname>Karam</surname><given-names>JR</given-names></name><name><surname>Lee</surname><given-names>PR</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Koenig</surname><given-names>JI</given-names></name><etal></etal></person-group>
<article-title>Centrally administered oxytocin elicits exaggerated grooming in oxytocin null mice</article-title>. <source/>Pharmacol Biochem Behav (<year>2004</year>) <volume>78</volume>:<fpage>333</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.pbb.2004.04.006</pub-id><pub-id pub-id-type="pmid">15219775</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calcagnoli</surname><given-names>F</given-names></name><name><surname>Stubbendorff</surname><given-names>C</given-names></name><name><surname>Meyer</surname><given-names>N</given-names></name><name><surname>de Boer</surname><given-names>SF</given-names></name><name><surname>Althaus</surname><given-names>M</given-names></name><name><surname>Koolhaas</surname><given-names>JM</given-names></name></person-group>. <article-title>Oxytocin microinjected into the central amygdaloid nuclei exerts anti-aggressive effects in male rats</article-title>. <source/>Neuropharmacology (<year>2015</year>) <volume>90</volume>:<fpage>74</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.11.012</pub-id><pub-id pub-id-type="pmid">25437825</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzman</surname><given-names>YF</given-names></name><name><surname>Tronson</surname><given-names>NC</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Mesic</surname><given-names>I</given-names></name><name><surname>Guedea</surname><given-names>AL</given-names></name><name><surname>Nishimori</surname><given-names>K</given-names></name><etal></etal></person-group>
<article-title>Role of oxytocin receptors in modulation of fear by social memory</article-title>. <source/>Psychopharmacology (<year>2013</year>) <volume>231</volume>:<fpage>2097</fpage>–<lpage>105</lpage>.<pub-id pub-id-type="doi">10.1007/s00213-013-3356-6</pub-id><pub-id pub-id-type="pmid">24287604</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzman</surname><given-names>YF</given-names></name><name><surname>Tronson</surname><given-names>NC</given-names></name><name><surname>Jovasevic</surname><given-names>V</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Guedea</surname><given-names>AL</given-names></name><name><surname>Mizukami</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>Fear-enhancing effects of septal oxytocin receptors</article-title>. <source/>Nat Neurosci (<year>2013</year>) <volume>16</volume>:<fpage>1185</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/nn.3465</pub-id><pub-id pub-id-type="pmid">23872596</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Insel</surname><given-names>TR</given-names></name><name><surname>Young</surname><given-names>L</given-names></name><name><surname>Witt</surname><given-names>DM</given-names></name><name><surname>Crews</surname><given-names>D</given-names></name></person-group>. <article-title>Gonadal steroids have paradoxical effects on brain oxytocin receptors</article-title>. <source/>J Neuroendocrinol (<year>1993</year>) <volume>5</volume>:<fpage>619</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2826.1993.tb00531.x</pub-id><pub-id pub-id-type="pmid">8680433</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boccia</surname><given-names>ML</given-names></name><name><surname>Petrusz</surname><given-names>P</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Marson</surname><given-names>L</given-names></name><name><surname>Pedersen</surname><given-names>CA</given-names></name></person-group>. <article-title>Immunohistochemical localization of oxytocin receptors in human brain</article-title>. <source/>Neuroscience (<year>2013</year>) <volume>253</volume>:<fpage>155</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.08.048</pub-id><pub-id pub-id-type="pmid">24012742</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukas</surname><given-names>M</given-names></name><name><surname>Bredewold</surname><given-names>R</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name><name><surname>Veenema</surname><given-names>AH</given-names></name></person-group>. <article-title>Maternal separation interferes with developmental changes in brain vasopressin and oxytocin receptor binding in male rats</article-title>. <source/>Neuropharmacology (<year>2010</year>) <volume>58</volume>:<fpage>78</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuropharm.2009.06.020</pub-id><pub-id pub-id-type="pmid">19560475</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumais</surname><given-names>KM</given-names></name><name><surname>Bredewold</surname><given-names>R</given-names></name><name><surname>Mayer</surname><given-names>TE</given-names></name><name><surname>Veenema</surname><given-names>AH</given-names></name></person-group>. <article-title>Sex differences in oxytocin receptor binding in forebrain regions: correlations with social interest in brain region-and sex- specific ways</article-title>. <source/>Horm Behav (<year>2013</year>) <volume>64</volume>:<fpage>693</fpage>–<lpage>701</lpage>.<pub-id pub-id-type="doi">10.1016/j.yhbeh.2013.08.012</pub-id><pub-id pub-id-type="pmid">24055336</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rilling</surname><given-names>JK</given-names></name><name><surname>Demarco</surname><given-names>AC</given-names></name><name><surname>Hackett</surname><given-names>PD</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Gautam</surname><given-names>P</given-names></name><name><surname>Stair</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Sex differences in the neural and behavioral response to intranasal oxytocin and vasopressin during human social interaction</article-title>. <source/>Psychoneuroendocrinology (<year>2014</year>) <volume>39</volume>:<fpage>237</fpage>–<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1016/j.psyneuen.2013.09.022</pub-id><pub-id pub-id-type="pmid">24157401</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheele</surname><given-names>D</given-names></name><name><surname>Striepens</surname><given-names>N</given-names></name><name><surname>Kendrick</surname><given-names>KM</given-names></name><name><surname>Schwering</surname><given-names>C</given-names></name><name><surname>Noelle</surname><given-names>J</given-names></name><name><surname>Wille</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Opposing effects of oxytocin on moral judgment in males and females</article-title>. <source/>Hum Brain Mapp (<year>2014</year>) <volume>35</volume>:<fpage>6067</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="doi">10.1002/hbm.22605</pub-id><pub-id pub-id-type="pmid">25094043</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>R</given-names></name></person-group>. <article-title>Chronic stress, drug use, and vulnerability to addiction</article-title>. <source/>Ann N Y Acad Sci (<year>2008</year>) <volume>1141</volume>:<fpage>105</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1196/annals.1441.030</pub-id><pub-id pub-id-type="pmid">18991954</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlosser</surname><given-names>SF</given-names></name><name><surname>Almeida</surname><given-names>OF</given-names></name><name><surname>Patchev</surname><given-names>VK</given-names></name><name><surname>Yassouridis</surname><given-names>A</given-names></name><name><surname>Elands</surname><given-names>J</given-names></name></person-group>. <article-title>Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type</article-title>. <source/>Endocrinology (<year>1994</year>) <volume>135</volume>:<fpage>2058</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1210/endo.135.5.7956927</pub-id><pub-id pub-id-type="pmid">7956927</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>ID</given-names></name></person-group>. <article-title>Stimuli and consequences of dendritic release of oxytocin within the brain</article-title>. <source/>Biochem Soc Trans (<year>2007</year>) <volume>35</volume>:<fpage>1252</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1042/BST0351252</pub-id><pub-id pub-id-type="pmid">17956324</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Windle</surname><given-names>RJ</given-names></name><name><surname>Shanks</surname><given-names>N</given-names></name><name><surname>Lightman</surname><given-names>SL</given-names></name><name><surname>Ingram</surname><given-names>CD</given-names></name></person-group>. <article-title>Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats</article-title>. <source/>Endocrinology (<year>1997</year>) <volume>138</volume>:<fpage>2829</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1210/en.138.7.2829</pub-id><pub-id pub-id-type="pmid">9202224</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Windle</surname><given-names>RJ</given-names></name><name><surname>Kershaw</surname><given-names>YM</given-names></name><name><surname>Shanks</surname><given-names>N</given-names></name><name><surname>Wood</surname><given-names>SA</given-names></name><name><surname>Lightman</surname><given-names>SL</given-names></name><name><surname>Ingram</surname><given-names>CD</given-names></name></person-group>. <article-title>Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity</article-title>. <source/>J Neurosci (<year>2004</year>) <volume>24</volume>:<fpage>2974</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3432-03.2004</pub-id><pub-id pub-id-type="pmid">15044536</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantella</surname><given-names>RC</given-names></name><name><surname>Vollmer</surname><given-names>RR</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Amico</surname><given-names>JA</given-names></name></person-group>. <article-title>Female oxytocin-deficient mice display enhanced anxiety-related behavior</article-title>. <source/>Endocrinology (<year>2003</year>) <volume>144</volume>:<fpage>2291</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1210/en.2002-0197</pub-id><pub-id pub-id-type="pmid">12746288</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amico</surname><given-names>JA</given-names></name><name><surname>Mantella</surname><given-names>RC</given-names></name><name><surname>Vollmer</surname><given-names>RR</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group>. <article-title>Anxiety and stress responses in female oxytocin deficient mice</article-title>. <source/>J Neuroendocrinol (<year>2004</year>) <volume>16</volume>:<fpage>319</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1111/j.0953-8194.2004.01161.x</pub-id><pub-id pub-id-type="pmid">15089969</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>ID</given-names></name><name><surname>Kromer</surname><given-names>SA</given-names></name><name><surname>Toschi</surname><given-names>N</given-names></name><name><surname>Ebner</surname><given-names>K</given-names></name></person-group>. <article-title>Brain oxytocin inhibits the (re)activity of the hypothalamo-pituitary-adrenal axis in male rats: involvement of hypothalamic and limbic brain regions</article-title>. <source/>Regul Pept (<year>2000</year>) <volume>96</volume>:<fpage>31</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/S0167-0115(00)00197-X</pub-id><pub-id pub-id-type="pmid">11102649</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>ID</given-names></name><name><surname>Wigger</surname><given-names>A</given-names></name><name><surname>Torner</surname><given-names>L</given-names></name><name><surname>Holsboer</surname><given-names>F</given-names></name><name><surname>Landgraf</surname><given-names>R</given-names></name></person-group>. <article-title>Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo-pituitary-adrenal axis in male and female rats: partial action within the paraventricular nucleus</article-title>. <source/>J Neuroendocrinol (<year>2000</year>) <volume>12</volume>:<fpage>235</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1046/j.1365-2826.2000.00442.x</pub-id><pub-id pub-id-type="pmid">10718919</pub-id></mixed-citation>
</ref>
<ref id="B36">
<label>36</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>AS</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name></person-group>. <article-title>Hypothalamic oxytocin mediates social buffering of the stress response</article-title>. <source/>Biol Psychiatry (<year>2014</year>) <volume>76</volume>:<fpage>281</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.biopsych.2013.09.017</pub-id><pub-id pub-id-type="pmid">24183103</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>HE</given-names></name><name><surname>Young</surname><given-names>LJ</given-names></name></person-group>. <article-title>Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior</article-title>. <source/>Front Neuroendocrinol (<year>2009</year>) <volume>30</volume>:<fpage>534</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1016/j.yfrne.2009.05.004</pub-id><pub-id pub-id-type="pmid">19481567</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ter Horst</surname><given-names>JP</given-names></name><name><surname>de Kloet</surname><given-names>ER</given-names></name><name><surname>Schachinger</surname><given-names>H</given-names></name><name><surname>Oitzl</surname><given-names>MS</given-names></name></person-group>. <article-title>Relevance of stress and female sex hormones for emotion and cognition</article-title>. <source/>Cell Mol Neurobiol (<year>2012</year>) <volume>32</volume>:<fpage>725</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1007/s10571-011-9774-2</pub-id><pub-id pub-id-type="pmid">22113371</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carson</surname><given-names>DS</given-names></name><name><surname>Berquist</surname><given-names>SW</given-names></name><name><surname>Trujillo</surname><given-names>TH</given-names></name><name><surname>Garner</surname><given-names>JP</given-names></name><name><surname>Hannah</surname><given-names>SL</given-names></name><name><surname>Hyde</surname><given-names>SA</given-names></name><etal></etal></person-group>
<article-title>Cerebrospinal fluid and plasma oxytocin concentrations are positively correlated and negatively predict anxiety in children</article-title>. <source/>Mol Psychiatry (<year>2014</year>) <volume>20</volume>:<fpage>1085</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1038/mp.2014.132</pub-id><pub-id pub-id-type="pmid">25349162</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>FL</given-names></name><name><surname>Weisman</surname><given-names>O</given-names></name><name><surname>Feldman</surname><given-names>R</given-names></name><name><surname>Hurley</surname><given-names>RA</given-names></name><name><surname>Taber</surname><given-names>KH</given-names></name></person-group>
<article-title>Oxytocin and behavior: evidence for effects in the brain</article-title>. <source/>J Neuropsychiatry Clin Neurosci (<year>2013</year>) <volume>25</volume>:<fpage>96</fpage>–<lpage>102</lpage>.<pub-id pub-id-type="doi">10.1176/appi.neuropsych.13030061</pub-id><pub-id pub-id-type="pmid">23686025</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cochran</surname><given-names>DM</given-names></name><name><surname>Fallon</surname><given-names>D</given-names></name><name><surname>Hill</surname><given-names>M</given-names></name><name><surname>Frazier</surname><given-names>JA</given-names></name></person-group>. <article-title>The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings</article-title>. <source/>Harv Rev Psychiatry (<year>2013</year>) <volume>21</volume>:<fpage>219</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1097/HRP.0b013e3182a75b7d</pub-id><pub-id pub-id-type="pmid">24651556</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bendix</surname><given-names>M</given-names></name><name><surname>Uvnas-Moberg</surname><given-names>K</given-names></name><name><surname>Petersson</surname><given-names>M</given-names></name><name><surname>Gustavsson</surname><given-names>P</given-names></name><name><surname>Svanborg</surname><given-names>P</given-names></name><name><surname>Asberg</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Plasma oxytocin and personality traits in psychiatric outpatients</article-title>. <source/>Psychoneuroendocrinology (<year>2015</year>) <volume>57</volume>:<fpage>102</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="doi">10.1016/j.psyneuen.2015.04.003</pub-id><pub-id pub-id-type="pmid">25910979</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofmann</surname><given-names>SG</given-names></name><name><surname>Fang</surname><given-names>A</given-names></name><name><surname>Brager</surname><given-names>DN</given-names></name></person-group>. <article-title>Effect of intranasal oxytocin administration on psychiatric symptoms: a meta-analysis of placebo-controlled studies</article-title>. <source/>Psychiatry Res (<year>2015</year>) <volume>228</volume>:<fpage>708</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1016/j.psychres.2015.05.039</pub-id><pub-id pub-id-type="pmid">26094200</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eaton</surname><given-names>JL</given-names></name><name><surname>Roache</surname><given-names>L</given-names></name><name><surname>Nguyen</surname><given-names>KN</given-names></name><name><surname>Cushing</surname><given-names>BS</given-names></name><name><surname>Troyer</surname><given-names>E</given-names></name><name><surname>Papademetriou</surname><given-names>E</given-names></name><etal></etal></person-group>
<article-title>Organizational effects of oxytocin on serotonin innervation</article-title>. <source/>Dev Psychobiol (<year>2012</year>) <volume>54</volume>:<fpage>92</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1002/dev.20566</pub-id><pub-id pub-id-type="pmid">21594870</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blume</surname><given-names>A</given-names></name><name><surname>Bosch</surname><given-names>OJ</given-names></name><name><surname>Miklos</surname><given-names>S</given-names></name><name><surname>Torner</surname><given-names>L</given-names></name><name><surname>Wales</surname><given-names>L</given-names></name><name><surname>Waldherr</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus</article-title>. <source/>Eur J Neurosci (<year>2008</year>) <volume>27</volume>:<fpage>1947</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1111/j.1460-9568.2008.06184.x</pub-id><pub-id pub-id-type="pmid">18412615</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabihi</surname><given-names>S</given-names></name><name><surname>Durosko</surname><given-names>NE</given-names></name><name><surname>Dong</surname><given-names>SM</given-names></name><name><surname>Leuner</surname><given-names>B</given-names></name></person-group>. <article-title>Oxytocin in the prelimbic medial prefrontal cortex reduces anxiety-like behavior in female and male rats</article-title>. <source/>Psychoneuroendocrinology (<year>2014</year>) <volume>45</volume>:<fpage>31</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1016/j.psyneuen.2014.03.009</pub-id><pub-id pub-id-type="pmid">24845174</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slattery</surname><given-names>DA</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name></person-group>. <article-title>Chronic ICV oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats</article-title>. <source/>Neuropharmacology (<year>2010</year>) <volume>58</volume>:<fpage>56</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuropharm.2009.06.038</pub-id><pub-id pub-id-type="pmid">19589349</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winslow</surname><given-names>JT</given-names></name><name><surname>Hearn</surname><given-names>EF</given-names></name><name><surname>Ferguson</surname><given-names>J</given-names></name><name><surname>Young</surname><given-names>LJ</given-names></name><name><surname>Matzuk</surname><given-names>MM</given-names></name><name><surname>Insel</surname><given-names>TR</given-names></name></person-group>. <article-title>Infant vocalization, adult aggression, and fear behavior of an oxytocin null mutant mouse</article-title>. <source/>Horm Behav (<year>2000</year>) <volume>37</volume>:<fpage>145</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1006/hbeh.1999.1566</pub-id><pub-id pub-id-type="pmid">10753584</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaviaras</surname><given-names>S</given-names></name><name><surname>Mak</surname><given-names>P</given-names></name><name><surname>Ralph</surname><given-names>D</given-names></name><name><surname>Krishnan</surname><given-names>L</given-names></name><name><surname>Broadbear</surname><given-names>JH</given-names></name></person-group>. <article-title>Assessing the antidepressant-like effects of carbetocin, an oxytocin agonist, using a modification of the forced swimming test</article-title>. <source/>Psychopharmacology (<year>2010</year>) <volume>210</volume>:<fpage>35</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1007/s00213-010-1815-x</pub-id><pub-id pub-id-type="pmid">20232054</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ring</surname><given-names>RH</given-names></name><name><surname>Schechter</surname><given-names>LE</given-names></name><name><surname>Leonard</surname><given-names>SK</given-names></name><name><surname>Dwyer</surname><given-names>JM</given-names></name><name><surname>Platt</surname><given-names>BJ</given-names></name><name><surname>Graf</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist</article-title>. <source/>Neuropharmacology (<year>2010</year>) <volume>58</volume>:<fpage>69</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuropharm.2009.07.016</pub-id><pub-id pub-id-type="pmid">19615387</pub-id></mixed-citation>
</ref>
<ref id="B51">
<label>51</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>YL</given-names></name><name><surname>Su</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>SX</given-names></name><name><surname>Liu</surname><given-names>AJ</given-names></name><etal></etal></person-group>
<article-title>Effect of oxytocin on the behavioral activity in the behavioral despair depression rat model</article-title>. <source/>Neuropeptides (<year>2014</year>) <volume>48</volume>:<fpage>83</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.npep.2014.01.001</pub-id><pub-id pub-id-type="pmid">24444823</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beato</surname><given-names>M</given-names></name><name><surname>Klug</surname><given-names>J</given-names></name></person-group>. <article-title>Steroid hormone receptors: an update</article-title>. <source/>Hum Reprod Update (<year>2000</year>) <volume>6</volume>:<fpage>225</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1093/humupd/6.3.225</pub-id><pub-id pub-id-type="pmid">10874567</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiocchetti</surname><given-names>M</given-names></name><name><surname>Ascenzi</surname><given-names>P</given-names></name><name><surname>Marino</surname><given-names>M</given-names></name></person-group>. <article-title>Neuroprotective effects of 17beta-estradiol rely on estrogen receptor membrane initiated signals</article-title>. <source/>Front Physiol (<year>2012</year>) <volume>3</volume>:<fpage>73</fpage>.<pub-id pub-id-type="doi">10.3389/fphys.2012.00073</pub-id><pub-id pub-id-type="pmid">22493583</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>MM</given-names></name><name><surname>McDonald</surname><given-names>CH</given-names></name><name><surname>Brooks</surname><given-names>PJ</given-names></name><name><surname>Goldman</surname><given-names>D</given-names></name></person-group>. <article-title>An anxiolytic action of oxytocin is enhanced by estrogen in the mouse</article-title>. <source/>Physiol Behav (<year>1996</year>) <volume>60</volume>:<fpage>1209</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1016/S0031-9384(96)00212-0</pub-id><pub-id pub-id-type="pmid">8916173</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>LJ</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Donaldson</surname><given-names>R</given-names></name><name><surname>Rissman</surname><given-names>EF</given-names></name></person-group>. <article-title>Estrogen receptor alpha is essential for induction of oxytocin receptor by estrogen</article-title>. <source/>Neuroreport (<year>1998</year>) <volume>9</volume>:<fpage>933</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1097/00001756-199803300-00031</pub-id><pub-id pub-id-type="pmid">9579693</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiodera</surname><given-names>P</given-names></name><name><surname>Volpi</surname><given-names>R</given-names></name><name><surname>Capretti</surname><given-names>L</given-names></name><name><surname>Marchesi</surname><given-names>C</given-names></name><name><surname>d’Amato</surname><given-names>L</given-names></name><name><surname>De Ferri</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Effect of estrogen or insulin-induced hypoglycemia on plasma oxytocin levels in bulimia and anorexia nervosa</article-title>. <source/>Metabolism (<year>1991</year>) <volume>40</volume>:<fpage>1226</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1016/0026-0495(91)90220-Q</pub-id><pub-id pub-id-type="pmid">1943752</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grazzini</surname><given-names>E</given-names></name><name><surname>Guillon</surname><given-names>G</given-names></name><name><surname>Mouillac</surname><given-names>B</given-names></name><name><surname>Zingg</surname><given-names>HH</given-names></name></person-group>. <article-title>Inhibition of oxytocin receptor function by direct binding of progesterone</article-title>. <source/>Nature (<year>1998</year>) <volume>392</volume>:<fpage>509</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1038/33176</pub-id><pub-id pub-id-type="pmid">9548257</pub-id></mixed-citation>
</ref>
<ref id="B58">
<label>58</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patchev</surname><given-names>VK</given-names></name><name><surname>Schlosser</surname><given-names>SF</given-names></name><name><surname>Hassan</surname><given-names>AH</given-names></name><name><surname>Almeida</surname><given-names>OF</given-names></name></person-group>. <article-title>Oxytocin binding sites in rat limbic and hypothalamic structures: site-specific modulation by adrenal and gonadal steroids</article-title>. <source/>Neuroscience (<year>1993</year>) <volume>57</volume>:<fpage>537</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1016/0306-4522(93)90003-X</pub-id><pub-id pub-id-type="pmid">8309522</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handa</surname><given-names>RJ</given-names></name><name><surname>Nunley</surname><given-names>KM</given-names></name><name><surname>Lorens</surname><given-names>SA</given-names></name><name><surname>Louie</surname><given-names>JP</given-names></name><name><surname>McGivern</surname><given-names>RF</given-names></name><name><surname>Bollnow</surname><given-names>MR</given-names></name></person-group>. <article-title>Androgen regulation of adrenocorticotropin and corticosterone secretion in the male rat following novelty and foot shock stressors</article-title>. <source/>Physiol Behav (<year>1994</year>) <volume>55</volume>:<fpage>117</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1016/0031-9384(94)90018-3</pub-id><pub-id pub-id-type="pmid">8140154</pub-id></mixed-citation>
</ref>
<ref id="B60">
<label>60</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lund</surname><given-names>TD</given-names></name><name><surname>Munson</surname><given-names>DJ</given-names></name><name><surname>Haldy</surname><given-names>ME</given-names></name><name><surname>Handa</surname><given-names>RJ</given-names></name></person-group>. <article-title>Androgen inhibits, while oestrogen enhances, restraint-induced activation of neuropeptide neurones in the paraventricular nucleus of the hypothalamus</article-title>. <source/>J Neuroendocrinol (<year>2004</year>) <volume>16</volume>:<fpage>272</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/j.0953-8194.2004.01167.x</pub-id><pub-id pub-id-type="pmid">15049858</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Bisschop</surname><given-names>PH</given-names></name><name><surname>Eggels</surname><given-names>L</given-names></name><name><surname>Foppen</surname><given-names>E</given-names></name><name><surname>Fliers</surname><given-names>E</given-names></name><name><surname>Zhou</surname><given-names>JN</given-names></name><etal></etal></person-group>
<article-title>Intrahypothalamic estradiol modulates hypothalamus-pituitary-adrenal-axis activity in female rats</article-title>. <source/>Endocrinology (<year>2012</year>) <volume>153</volume>:<fpage>3337</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1210/en.2011-2176</pub-id><pub-id pub-id-type="pmid">22562172</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochedalski</surname><given-names>T</given-names></name><name><surname>Subburaju</surname><given-names>S</given-names></name><name><surname>Wynn</surname><given-names>PC</given-names></name><name><surname>Aguilera</surname><given-names>G</given-names></name></person-group>. <article-title>Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity</article-title>. <source/>J Neuroendocrinol (<year>2007</year>) <volume>19</volume>:<fpage>189</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2826.2006.01525.x</pub-id><pub-id pub-id-type="pmid">17280592</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serova</surname><given-names>LI</given-names></name><name><surname>Harris</surname><given-names>HA</given-names></name><name><surname>Maharjan</surname><given-names>S</given-names></name><name><surname>Sabban</surname><given-names>EL</given-names></name></person-group>. <article-title>Modulation of responses to stress by estradiol benzoate and selective estrogen receptor agonists</article-title>. <source/>J Endocrinol (<year>2010</year>) <volume>205</volume>:<fpage>253</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1677/JOE-10-0029</pub-id><pub-id pub-id-type="pmid">20348154</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lund</surname><given-names>TD</given-names></name><name><surname>Rovis</surname><given-names>T</given-names></name><name><surname>Chung</surname><given-names>WC</given-names></name><name><surname>Handa</surname><given-names>RJ</given-names></name></person-group>. <article-title>Novel actions of estrogen receptor-beta on anxiety-related behaviors</article-title>. <source/>Endocrinology (<year>2005</year>) <volume>146</volume>:<fpage>797</fpage>–<lpage>807</lpage>.<pub-id pub-id-type="doi">10.1210/en.2004-1158</pub-id><pub-id pub-id-type="pmid">15514081</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nomura</surname><given-names>M</given-names></name><name><surname>McKenna</surname><given-names>E</given-names></name><name><surname>Korach</surname><given-names>KS</given-names></name><name><surname>Pfaff</surname><given-names>DW</given-names></name><name><surname>Ogawa</surname><given-names>S</given-names></name></person-group>. <article-title>Estrogen receptor-beta regulates transcript levels for oxytocin and arginine vasopressin in the hypothalamic paraventricular nucleus of male mice</article-title>. <source/>Brain Res Mol Brain Res (<year>2002</year>) <volume>109</volume>:<fpage>84</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1016/S0169-328X(02)00525-9</pub-id><pub-id pub-id-type="pmid">12531518</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patisaul</surname><given-names>HB</given-names></name><name><surname>Scordalakes</surname><given-names>EM</given-names></name><name><surname>Young</surname><given-names>LJ</given-names></name><name><surname>Rissman</surname><given-names>EF</given-names></name></person-group>. <article-title>Oxytocin, but not oxytocin receptor, is rRegulated by oestrogen receptor beta in the female mouse hypothalamus</article-title>. <source/>J Neuroendocrinol (<year>2003</year>) <volume>15</volume>:<fpage>787</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1046/j.1365-2826.2003.01061.x</pub-id><pub-id pub-id-type="pmid">12834440</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiroi</surname><given-names>R</given-names></name><name><surname>Lacagnina</surname><given-names>AF</given-names></name><name><surname>Hinds</surname><given-names>LR</given-names></name><name><surname>Carbone</surname><given-names>DG</given-names></name><name><surname>Uht</surname><given-names>RM</given-names></name><name><surname>Handa</surname><given-names>RJ</given-names></name></person-group>. <article-title>The androgen metabolite, 5alpha-androstane-3beta,17beta-diol (3beta-diol), activates the oxytocin promoter through an estrogen receptor-beta pathway</article-title>. <source/>Endocrinology (<year>2013</year>) <volume>154</volume>:<fpage>1802</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1210/en.2012-2253</pub-id><pub-id pub-id-type="pmid">23515287</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oyola</surname><given-names>MG</given-names></name><name><surname>Portillo</surname><given-names>W</given-names></name><name><surname>Reyna</surname><given-names>A</given-names></name><name><surname>Foradori</surname><given-names>CD</given-names></name><name><surname>Kudwa</surname><given-names>A</given-names></name><name><surname>Hinds</surname><given-names>L</given-names></name><etal></etal></person-group>
<article-title>Anxiolytic effects and neuroanatomical targets of estrogen receptor-beta (ERbeta) activation by a selective ERbeta agonist in female mice</article-title>. <source/>Endocrinology (<year>2012</year>) <volume>153</volume>:<fpage>837</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="doi">10.1210/en.2011-1674</pub-id><pub-id pub-id-type="pmid">22186418</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lund</surname><given-names>TD</given-names></name><name><surname>Munson</surname><given-names>DJ</given-names></name><name><surname>Haldy</surname><given-names>ME</given-names></name><name><surname>Handa</surname><given-names>RJ</given-names></name></person-group>. <article-title>Dihydrotestosterone may inhibit hypothalamo-pituitary-adrenal activity by acting through estrogen receptor in the male mouse</article-title>. <source/>Neurosci Lett (<year>2004</year>) <volume>365</volume>:<fpage>43</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.neulet.2004.04.035</pub-id><pub-id pub-id-type="pmid">15234470</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kudwa</surname><given-names>AE</given-names></name><name><surname>McGivern</surname><given-names>RF</given-names></name><name><surname>Handa</surname><given-names>RJ</given-names></name></person-group>. <article-title>Estrogen receptor beta and oxytocin interact to modulate anxiety-like behavior and neuroendocrine stress reactivity in adult male and female rats</article-title>. <source/>Physiol Behav (<year>2014</year>) <volume>129</volume>:<fpage>287</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1016/j.physbeh.2014.03.004</pub-id><pub-id pub-id-type="pmid">24631553</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krezel</surname><given-names>W</given-names></name><name><surname>Dupont</surname><given-names>S</given-names></name><name><surname>Krust</surname><given-names>A</given-names></name><name><surname>Chambon</surname><given-names>P</given-names></name><name><surname>Chapman</surname><given-names>PF</given-names></name></person-group>. <article-title>Increased anxiety and synaptic plasticity in estrogen receptor beta-deficient mice</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2001</year>) <volume>98</volume>:<fpage>12278</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.221451898</pub-id><pub-id pub-id-type="pmid">11593044</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>S</given-names></name><name><surname>Handa</surname><given-names>RJ</given-names></name></person-group>. <article-title>Estrogen receptor-beta, but not estrogen receptor-alpha, is expressed in prolactin neurons of the female rat paraventricular and supraoptic nuclei: comparison with other neuropeptides</article-title>. <source/>J Comp Neurol (<year>2005</year>) <volume>484</volume>:<fpage>28</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1002/cne.20457</pub-id><pub-id pub-id-type="pmid">15717309</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lund</surname><given-names>TD</given-names></name><name><surname>Hinds</surname><given-names>LR</given-names></name><name><surname>Handa</surname><given-names>RJ</given-names></name></person-group>. <article-title>The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha-androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus</article-title>. <source/>J Neurosci (<year>2006</year>) <volume>26</volume>:<fpage>1448</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3777-05.2006</pub-id><pub-id pub-id-type="pmid">16452668</pub-id></mixed-citation>
</ref>
<ref id="B74">
<label>74</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>D</given-names></name><name><surname>Handa</surname><given-names>RJ</given-names></name><name><surname>Uht</surname><given-names>RM</given-names></name></person-group>. <article-title>The ERbeta ligand 5alpha-androstane, 3beta,17beta-diol (3beta-diol) regulates hypothalamic oxytocin (Oxt) gene expression</article-title>. <source/>Endocrinology (<year>2012</year>) <volume>153</volume>:<fpage>2353</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1210/en.2011-1002</pub-id><pub-id pub-id-type="pmid">22434086</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burbach</surname><given-names>JP</given-names></name><name><surname>Luckman</surname><given-names>SM</given-names></name><name><surname>Murphy</surname><given-names>D</given-names></name><name><surname>Gainer</surname><given-names>H</given-names></name></person-group>. <article-title>Gene regulation in the magnocellular hypothalamo-neurohypophysial system</article-title>. <source/>Physiol Rev (<year>2001</year>) <volume>81</volume>:<fpage>1197</fpage>–<lpage>267</lpage>.<pub-id pub-id-type="pmid">11427695</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>